We are live on ! Find out more
COEPW

Coeptis Therapeutics Warrants
COEPW

Delisted

COEPW was delisted on the 24th of April, 2026.

Back to rankings

23 hedge funds and large institutions have $843K invested in Coeptis Therapeutics Warrants in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

15% less funds holding

Funds holding: 27 → 23 (-4)

18% less capital invested

Capital invested by funds: $1.03M → $843K (-$184K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 4

Holders
23
Holders Change
-4
Holders Change %
-14.81%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
3
Reduced
2
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SIA
SkyView Investment Advisors
New Jersey
+$1.68K
2
UBS Group
UBS Group
Switzerland
+$134
3
HF
HRT Financial
New York
+$5

Top Sellers

Rank Fund Capital Flow
1
BFM
Boothbay Fund Management
New York
-$151K
2
MC
Meteora Capital
Florida
-$18K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1.13K
4
SSA
Schonfeld Strategic Advisors
New York
-$1K
5
LCM
Landscape Capital Management
New Jersey
-$130
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
Radcliffe Capital Management
Pennsylvania
$763K – – –
BCM
2
Basso Capital Management
Connecticut
$15K – – –
ICM
3
Ionic Capital Management
New York
$13K – – –
KC
4
Kepos Capital
New York
$8K – – –
OCAM
5
Owl Creek Asset Management
New York
$6K – – –
RCM
6
Rivernorth Capital Management
Florida
$5K – – –
Wells Fargo
7
Wells Fargo
California
$5K – – –
AA
8
AQR Arbitrage
Connecticut
$4K – – –
CF
9
Cantor Fitzgerald
New York
$3K – – –
PC
10
Periscope Capital
Ontario, Canada
$3K – – –
SCM
11
Shaolin Capital Management
Florida
$3K – – –
Walleye Capital
12
Walleye Capital
New York
$3K – – –
HF
13
HRT Financial
New York
$3K +$5 +100 +0.1%
Walleye Trading
14
Walleye Trading
New York
$2K – – –
SIA
15
SkyView Investment Advisors
New Jersey
$2K +$1.68K +35,070 +175%
Susquehanna International Group
16
Susquehanna International Group
Pennsylvania
$1K -$1.13K -23,461 -39%
LCM
17
Landscape Capital Management
New Jersey
$1K -$130 -2,712 -8%
CL
18
CSS LLC
Illinois
$1K – – –
HHGC
19
Hunting Hill Global Capital
New York
$1K – – –
SM
20
Skaana Management
New York
$1K – – –
MC
21
Meteora Capital
Florida
– -$18K -388,443 Closed
BFM
22
Boothbay Fund Management
New York
– -$151K -15,000 Closed
SSA
23
Schonfeld Strategic Advisors
New York
– -$1K -11,406 Closed
UBS Group
24
UBS Group
Switzerland
– +$134 +2,800 +27%

COEPW Hedge Fund Activity: Q3 2022 in Review

23 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Coeptis Therapeutics Warrants (COEPW) for Q3 2022, worth a combined $843K — down 18% from $1.03M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of COEPW and 0 opened new positions — a net loss of 4 holders — while 2 trimmed existing stakes and 3 added.

The largest buyer was SkyView Investment Advisors, adding an estimated $1.68K. The largest seller was Boothbay Fund Management, exiting entirely with an estimated $151K sold.

  • 23 institutional investors held Coeptis Therapeutics Warrants (COEPW) as of Q3 2022, down from 27 in Q2 2022.
  • Funds reported $843K of Coeptis Therapeutics Warrants stock for Q3 2022, down 18% quarter-over-quarter.
  • 0 funds opened new Coeptis Therapeutics Warrants positions in Q3 2022 and 4 closed out, a net change of -4 holders.
  • The largest Coeptis Therapeutics Warrants buyer in Q3 2022 was SkyView Investment Advisors, an estimated $1.68K added.
  • The largest Coeptis Therapeutics Warrants seller in Q3 2022 was Boothbay Fund Management, an estimated $151K sold.

Based on aggregated 13F filings for Q3 2022.